Low PHD1 mRNA expression was associated with a higher stage of disease (p = 0.0089), larger tumour size (p = 0.0002) and squamous cell carcinoma histology (p = 0.0065). The gene discussed is EGLN2; the disease is squamous cell carcinoma.